Browse products
Supply chain management in the pharmaceutical industry in Poland 2008 |
Polish version also available »
Our clients say...
Supply chain management in the pharmaceutical industry in Poland 2008 thoroughly examines the most innovative ways of gaining competitive advantage in the pharmaceutical sector. It studies the conditions and the level of advancement of the Supply Chain Management on the Polish market in the context of the best practices employed in Polish enterprises and worldwide. The concept itself is meticulously explained, focusing on drug production in Poland.
“As a London-based company, with operations abroad, we looked for the best-in-class Market Intelligence supplier. PMR brought us quality reports that improved our CEE market knowledge and understanding.”
Development Manager, GVA Grimley
“We consider PMR a competent and professional company. PMR analysts understand our needs clearly and their services have fully met our expectations. I strongly recommend the company as a reliable partner in providing economic information and market analysis.”
General Manager, Sanofi-Synthelabo
“PMR reports are a serious contribution to the market overview picture, focusing our attention on key events in the industry as well as highlighting both general and specific market indicators. Together, these components are the base for our future forecasts of construction market development and help us to plan our sales.
”
Market Analyst, Alpha Cement
“PMR's analysts understand our needs well and the standard of their service has always fully met our expectations. We are looking forward to cooperating with PMR in the future as well. ”
Senior Trade and Investment Adviser, British Embassy in Warsaw
“We use PMR's services due to their analysts' extensive experience in market analysis, their high quality and level of engagement in the market research carried out for us. We consider PMR a competent and professional company and recommend them as a reliable partner in the area of economic information and market analysis.”
Senior Trade and Investment Adviser, British Embassy in Warsaw
“Sanofi-Aventis group regularly order PMR's reports and newsletters concerning the Polish pharmaceutical market. We use PMR's services because of the wealth of experience of its analysts in undertaking market analysis and a high level of quality and involvement in the field of market research. ”
General Manager, Sanofi-Synthelabo
“PMR provides a good service and is always open to discussion. All reports are well structured & are always on time.”
Member of the Managment Board, SCA Hygiene Products
“It's a great pleasure to cooperate with PMR because of its analysts' wealth of experience in understanding the local market. We consider PMR a competent and professional company which helps us conduct our business. I would also like to state that PMR's team is always ready to respond to emerging customer needs. We can recommend it as a reliable partner.”
Business Analyst, Hilti Distribution, Russia
Key objectives and solutions offered by the SCM in Polish companies are provided on the basis of empirical data gathered specifically for the purpose of this report.
The report provides crucial information for anyone involved in supply management in the pharmaceutical sector in Poland and abroad, and particularly for:
- top management of pharmaceutical companies in Poland and abroad
- logistic operators active on the pharmaceutical market and those planning to enter it
- pharmaceutical company managers interested in implementing Supply Chain Management methods
- supply chain managers
- pharmaceutical distributors
- researchers, market analysts and consultants
- academic institutions
- those wanting to gain a thorough understanding of the Supply Chain Management concept.
Request sample pages/interactive screenshare
Report methodology
Introduction
Executive summary
Model of an excellent supply chain in the pharmaceutical industry
- Basic features of the supply chain
- Stages of SCM advancement
- Scope of research carried out for the purposes of the report
Diagnosis of supply chains of producers in the pharmaceutical industry
- Subjective structure of the supply chain
- Problems identified in the subjective structure of the drug supply chain in Poland
- Most important tendencies in the subjective structure of drug supply chains in Poland
- Objective structure of the supply chain
- Regulations of pharmaceutical products demand and supply
- Innovative and generic medicines
- Rx and OTC medicines
- Problems identified in the objective structure of supply chains in Poland
- Most important trends in the objective structure of drug supply chains in Poland
- Selected processes in the pharmaceutical supply chain
- Supply chain planning – synchronisation of demand and supply
- Customer service
- Physical distribution (transport, storage)
- Manufacturing
- Supplies (relations with suppliers)
- Redistribution – management of returns and waste
- Marketing activities
- Designing and launching new products
- Summary
Survey-based assessment of the level of SCM integration in the pharmaceutical industry in Poland
- Results of the survey carried out amongst companies present on the pharmaceutical market in Poland
- Sample characteristic
- Source of competitive edge in pharmaceutical companies in Poland
- Knowledge of SCM concepts in pharmaceutical companies in Poland
- Assessment of strategic gap in SCM in Poland
- Analysis of best practices – selected directions of improving SCM in the Polish pharmaceutical industry
- SCM strategies in the pharmaceutical industry
- Case study 1 – SCM strategy in Bayer Pharmaceuticals
- Internal SCM conditions in pharmacy (organisational structure supporting SCM)
- Case study 2 – Organisational changes in Becton Dickinson
- Case study 3 – Organisational structure for the Baxter Poland supply chain
- Pharmaceutical supply chain controlled by actual demand
- Case Study 4 – Direct distribution – Poltraf
- Case Study 5 – Joint forecasting and planning in Bayer AG
- Case study 6 – Demand management in the supply chain in Procter & Gamble
- Customer service in the pharmaceutical supply chain
- Case study 7 – Customer service in the supply chain of Procter & Gamble
- Leaning of the pharmaceutical supply chain – manufacturing processes
- Case study 8 – Lean production of copolymer producer
- Integration of suppliers by medicine producers
- Case study 9 – Integration of suppliers in a global pharmaceutical company
Premises and conditions of the development of SCM in the Polish pharmaceutical industry
- SCM and improved company competitiveness
- Opportunities and threats of SCM development in pharmaceutical companies in Poland
Annex 1 Detailed list of answers of respondents – SCM diagnosis in the Polish pharmaceutical industry
List of graphs
List of tables
About PMR
Contact PMR
List of graphs
- Report logics
- Components of the supply chain management excellence model
- Subjective structure of the pharmaceutical supply chain in Poland, 2008
- Example of price structure of non-reimbursed medicine in Poland, 2008
- Models of medicine distribution on the Polish market, 2008
- Comparison of traditional and network-based procedure of clinical test data management
- Place of surveyed companies in the supply chain in the pharmaceutical industry in Poland (number of companies), divided by business, 2008
- Companies participating in the survey of the pharmaceutical industry in Poland, according to product groups (number of companies), 2008
- Scope of operations of companies participating in the survey of the pharmaceutical industry in Poland (number of companies), 2008
- Source of capital in companies participating in the survey of the pharmaceutical industry in Poland (number of companies), 2008
- Area of competitive edge in companies participating in the survey of the pharmaceutical industry in Poland (number of companies), 2008
- Knowledge of SCM concepts in companies participating in the survey of the pharmaceutical industry in Poland (number of companies), 2008
- Position of the supply chain manager in companies participating in the survey of the pharmaceutical industry in Poland (number of companies), 2008
- SCM strategy model in Bayer Pharmaceuticals, 2008
- Traditional organisational structure of the Becton Dickinson supply chain, until mid 1990s
- New organisational structure of the Becton Dickinson supply chain, from mid 1990s
- Matrix organisational structure of the Baxter Polska supply chain, 2008
- Direct distribution model applied by Poltraf in Poland, 2008
- SCM goals in companies participating in the survey of the pharmaceutical industry in Poland (number of companies), 2008
- Reduction of the production process duration at the polymer producer
- Idea of balancing needs of producers and their suppliers proposed within ECR
- Supplier Development Positioning Matrix
List of tables
- Soft conditions of the SCM excellence model and scope of research carried out for the purposes of the report in the pharmaceutical industry in Poland, 2008
- Hard conditions of the SCM excellence model and scope of research carried out for the purposes of the report in the pharmaceutical industry in Poland, 2008
- Management elements – strategic issues in the SCM excellence model and scope of research carried out for the purposes of the report in the pharmaceutical industry in Poland, 2008
- Management elements – processes 1 in the SCM excellence model and scope of research carried out for the purposes of the report in the pharmaceutical industry in Poland, 2008
- Management elements – processes 2 in the SCM excellence model and scope of research carried out for the purposes of the report in the pharmaceutical industry in Poland, 2008
- Availability of individual groups of medicines in subsequent links of the distribution channel in Poland, 2008
- Place of performance of individual processes in the pharmaceutical supply chain in Poland, 2008
- SCM advancement levels in the pharmaceutical industry in Poland, soft and hard conditions, 2008
- Strategic approach in SCM in the pharmaceutical industry in Poland, 2008
- Advancement of SCM processes in the pharmaceutical industry in Poland, 2008
- Position of pharmaceutical supply chains in Poland in reference to the excellence model, 2008
- SCM result card (SCORCARD)
- Classification of pharmaceutical supply chains
- Features distinguishing individual types of pharmaceutical supply chains
- Division of operational costs in the pharmaceutical supply chain in the medical industry in the United States
- Costs of processes in the supply chain before and after implementation of the EHCR strategy
- Economies generated by individual solutions of the EHCR strategy
- Analysis of opportunities and threats for the performance of supply chain management assumptions in a pharmaceutical company in Poland, 2008
- SCM advancement levels in the pharmaceutical sector in Poland, soft and hard conditions (number of respondents), 2008
- Strategic approach in SCM in the pharmaceutical industry in Poland (number of respondents), 2008
- Application of SCM processes in the pharmaceutical industry in Poland (number of respondents), 2008
Supply chain management in the pharmaceutical industry in Poland 2008
Choose your version of this product:
| Language / Licence | Single | 5 Users | Corporate | Global |
| English or Polish | 1500€ | 2250€ | 3000€ | 3750€ |
| English and Polish | 2100€ | 3150€ | 4200€ | 5250€ |
Compare licences
- - for the product preservation: saving the product in the memory of one computer belonging to the client;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for the individual use of one person only, who is indicated by the client during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
- - for the product preservation: saving the product in the memory of 2 to 5 computers belonging to the organisation indicated by the client while purchasing process; these computers must be located in the same country as the organisation indicated during purchasing process;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for 2 to 5 people who work for the organisation indicated by the client during purchasing process, and who are in the same country as the organisation indicated during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
- - for the product preservation: saving the product in the memory of an unlimited number of computers belonging to the organisation indicated by the client during purchasing process; these computers must be located in the same country as the organisation indicated during purchasing process;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for an unlimited number of people who work for the organisation indicated by the client during purchasing process, who are in the same country as the organisation indicated during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
- - for the product preservation: saving the product in the memory of an unlimited number of computers belonging to the organisation indicated by the client during purchasing process; these computers can be located in or outside of the country of the organisation indicated during purchasing process;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for an unlimited number of people who work for the organisation indicated by the client during purchasing process, who are in or outside of the country of the organisation indicated during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.